Matthew Gross

1.6k total citations
27 papers, 750 citations indexed

About

Matthew Gross is a scholar working on Molecular Biology, Immunology and Biotechnology. According to data from OpenAlex, Matthew Gross has authored 27 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Biotechnology. Recurrent topics in Matthew Gross's work include Cancer Research and Treatments (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Matthew Gross is often cited by papers focused on Cancer Research and Treatments (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Matthew Gross collaborates with scholars based in United States, Australia and Netherlands. Matthew Gross's co-authors include Kirk W. Johnson, Barbara A. Holshouser, Stephen Ashwal, Jacob A. Kaizerman, Laura Sanftner, Roland W. Bürli, Heinz E. Moser, Wenhao Hu, Yigong Ge and Richard D. Tanaka and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Matthew Gross

26 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Gross United States 13 217 176 174 109 96 27 750
Parvinder K. Aley United Kingdom 15 310 1.4× 139 0.8× 80 0.5× 96 0.9× 121 1.3× 24 1.6k
Randy B. Howard United States 18 293 1.4× 71 0.4× 103 0.6× 50 0.5× 128 1.3× 31 922
P. Vedantham United States 11 699 3.2× 185 1.1× 191 1.1× 102 0.9× 88 0.9× 16 1.4k
Margaret E. Olson United States 19 384 1.8× 93 0.5× 78 0.4× 45 0.4× 55 0.6× 32 797
Chuan Bai China 16 303 1.4× 123 0.7× 122 0.7× 49 0.4× 182 1.9× 37 1.0k
Toshiaki Aoki Japan 13 294 1.4× 209 1.2× 132 0.8× 89 0.8× 56 0.6× 22 783
Maureen Highkin United States 14 274 1.3× 95 0.5× 52 0.3× 82 0.8× 108 1.1× 23 794
Michael Eder Austria 16 406 1.9× 85 0.5× 104 0.6× 20 0.2× 66 0.7× 59 1.0k
Paul C. Meunier United States 18 303 1.4× 81 0.5× 107 0.6× 35 0.3× 154 1.6× 30 1.2k
Claudia Bauer Germany 19 265 1.2× 225 1.3× 61 0.4× 31 0.3× 42 0.4× 43 933

Countries citing papers authored by Matthew Gross

Since Specialization
Citations

This map shows the geographic impact of Matthew Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Gross more than expected).

Fields of papers citing papers by Matthew Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Gross. The network helps show where Matthew Gross may publish in the future.

Co-authorship network of co-authors of Matthew Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Gross. A scholar is included among the top collaborators of Matthew Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Gross. Matthew Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Finlay, Keith, et al.. (2024). The Impact of Criminal Financial Sanctions: A Multistate Analysis of Survey and Administrative Data. RePEc: Research Papers in Economics. 6(4). 490–508. 1 indexed citations
2.
Finlay, Keith, et al.. (2023). The Impact of Criminal Financial Sanctions: A Multi-State Analysis of Survey and Administrative Data. SSRN Electronic Journal. 4 indexed citations
3.
Emberley, Ethan, Mark K. Bennett, Matthew Gross, et al.. (2018). Abstract 3509: The glutaminase inhibitor CB-839 synergizes with CDK4/6 and PARP inhibitors in pre-clinical tumor models. Cancer Research. 78(13_Supplement). 3509–3509. 12 indexed citations
4.
Works, Melissa, Mark K. Bennett, Ethan Emberley, et al.. (2016). Abstract 552: Immuno-oncology agent CB-1158 is a potent and selective arginase inhibitor and causes an immune-mediated anti-tumor response. Cancer Research. 76(14_Supplement). 552–552. 10 indexed citations
5.
Steggerda, Susanne, Mark K. Bennett, Jason Chen, et al.. (2016). Abstract B045: Arginase inhibitor CB-1158 elicits immune-mediated antitumor responses as a single agent and in combination with other immunotherapies. Cancer Immunology Research. 4(11_Supplement). B045–B045. 2 indexed citations
6.
Gross, Matthew, Jason Chen, Ethan Emberley, et al.. (2015). Abstract A195: CB-1158 inhibits the immuno-oncology target arginase and causes an immune mediated anti-tumor response. Molecular Cancer Therapeutics. 14(12_Supplement_2). A195–A195. 4 indexed citations
7.
Parlati, Francesco, Susan D. Demo, Matthew Gross, et al.. (2014). Abstract 1416: CB-839, a novel potent and selective glutaminase inhibitor, has broad antiproliferative activity in cell lines derived from both solid tumors and hematological malignancies. Cancer Research. 74(19_Supplement). 1416–1416. 12 indexed citations
8.
Parlati, Francesco, Tania Chernov-Rogan, Susan D. Demo, et al.. (2013). Abstract 1877: Anti-tumor activity of novel, potent, selective and orally-bioavailable glutaminase inhibitors.. Cancer Research. 73(8_Supplement). 1877–1877.
9.
Nguyen, Jack, Donald F. Smee, Dale L. Barnard, et al.. (2012). Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses. PLoS ONE. 7(1). e31006–e31006. 69 indexed citations
10.
Smee, Donald F., Justin G. Julander, E. Bart Tarbet, Matthew Gross, & Jack Nguyen. (2012). Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents. Antiviral Research. 96(1). 13–20. 16 indexed citations
11.
Gross, Matthew. (2011). Perceptions of Access to Education: Inclusion and Exclusion for Non-Karen Refugees in Mae La Camp. School for International Training Digital Collections (School for International Training). 1 indexed citations
12.
Britzi, Malka, Matthew Gross, Eran Lavy, S. Soback, & Amir Steinman. (2010). Bioavailability and pharmacokinetics of metronidazole in fed and fasted horses. Journal of Veterinary Pharmacology and Therapeutics. 33(5). 511–514. 9 indexed citations
13.
Sanftner, Laura, Jacqueline A. Gibbons, Matthew Gross, et al.. (2009). Cross-species comparisons of the pharmacokinetics of ibudilast. Xenobiotica. 39(12). 964–977. 26 indexed citations
14.
Rolan, Paul, Jacqueline A. Gibbons, D. Michael Jones, et al.. (2008). Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses. British Journal of Clinical Pharmacology. 66(6). 792–801. 58 indexed citations
15.
Ledeboer, Annemarie, Tongyao Liu, Jennifer A. Shumilla, et al.. (2006). The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. PubMed. 2(4). 279–291. 105 indexed citations
16.
Bürli, Roland W., Jacob A. Kaizerman, Jianxin Duan, et al.. (2004). DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids. Bioorganic & Medicinal Chemistry Letters. 14(9). 2067–2072. 15 indexed citations
17.
Ashwal, Stephen, et al.. (2004). Proton MR Spectroscopy Detected Glutamate/Glutamine Is Increased in Children with Traumatic Brain Injury. Journal of Neurotrauma. 21(11). 1539–1552. 65 indexed citations
18.
Ashwal, Stephen, et al.. (2004). Proton Spectroscopy Detected Myoinositol in Children with Traumatic Brain Injury. Pediatric Research. 56(4). 630–638. 85 indexed citations
19.
Gross, Matthew, Roland W. Bürli, Paul S. Jones, et al.. (2003). Pharmacology of Novel Heteroaromatic Polycycle Antibacterials. Antimicrobial Agents and Chemotherapy. 47(11). 3448–3457. 13 indexed citations
20.
Kaizerman, Jacob A., Matthew Gross, Yigong Ge, et al.. (2003). DNA Binding Ligands Targeting Drug-Resistant Bacteria:  Structure, Activity, and Pharmacology. Journal of Medicinal Chemistry. 46(18). 3914–3929. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Parvinder K. Aley Breakdown of academic impact, for papers by Randy B. Howard Breakdown of academic impact, for papers by P. Vedantham Breakdown of academic impact, for papers by Margaret E. Olson Breakdown of academic impact, for papers by Chuan Bai Breakdown of academic impact, for papers by Toshiaki Aoki Breakdown of academic impact, for papers by Maureen Highkin Breakdown of academic impact, for papers by Michael Eder Breakdown of academic impact, for papers by Paul C. Meunier Breakdown of academic impact, for papers by Claudia Bauer
Rankless by CCL
2026